Analgesic Effect of Inhaled Lavender Essential Oil for Clipping of Tongue-ties (LEO-SME1)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04877392 |
|
Recruitment Status :
Completed
First Posted : May 7, 2021
Last Update Posted : January 28, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Ankyloglossia | Dietary Supplement: Lavender essential oil | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 142 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Supportive Care |
| Official Title: | Analgesic Effect of Inhaled Lavender Essential Oil for Frenotomy in Healthy Neonates: a Randomized Clinical Trial |
| Actual Study Start Date : | August 18, 2020 |
| Actual Primary Completion Date : | April 15, 2021 |
| Actual Study Completion Date : | April 15, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: Control (usual measures to control pain)
The neonate was taken to the neonatal unit and monitored with a pulse-oximeter before, during and after the procedure. The neonate was swaddled, administered 1 mL of oral sucrose, and allowed to suck for 2 minutes prior to the procedure.
|
|
|
Experimental: Case (usual measures to control pain plus inhaled lavender essential oil)
The neonate was taken to the neonatal unit and monitored with a pulse-oximeter before, during and after the procedure. The neonate was swaddled, administered 1 mL of oral sucrose, and allowed to suck for 2 minutes prior to the procedure. The neonate also had a 7 x 7 cm gauze pad with 1 drop (43.75 mg) of 100% pure LEO (Pranarôm España S.L.) placed 2 cm under their nose for 2 minutes prior to starting the frenotomy and for the duration of the procedure.
|
Dietary Supplement: Lavender essential oil
Use of inhaled lavender essential oil |
- Crying length [ Time Frame: Up to 5 minutes post-procedure ]Crying length after the frenotomy in seconds
- NIPS score [ Time Frame: Up to 5 minutes post-procedure ]Neonatal Infant Pain Score value (0-7). NIPS evaluates facial expression, crying, breathing pattern, arm and leg position, and state of arousal on a scale from 0 to 7, where 0-2 means no pain to mild pain, 3-4 mild to moderate pain, and >4 severe pain.
- Change in heart rate [ Time Frame: Up to 5 minutes post-procedure ]Change in heart rate pre/post-procedure (beats per minute)
- Change in oxygen saturation [ Time Frame: Up to 5 minutes post-procedure ]Change in oxygen saturation (%)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | up to 15 Days (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Healthy full-term neonates born at Hospital del Mar (Barcelona, Spain), or less than 15 days old who had been discharged and returned for the frenotomy, who underwent a frenotomy for type 3 tongue-ties according to Coryllos classification and the Hazelbaker tool during the study period (August 2020 to April 2021)
Exclusion Criteria:
- Refusal of the patient's parents to participate
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04877392
| Spain | |
| Hospital del Mar | |
| Barcelona, Spain, 08003 | |
| Principal Investigator: | Montserrat Fàbregas-Mitjans, Ph.D. | Hospital del Mar |
Other Publications:
| Responsible Party: | Parc de Salut Mar |
| ClinicalTrials.gov Identifier: | NCT04877392 |
| Other Study ID Numbers: |
2020/9373/I |
| First Posted: | May 7, 2021 Key Record Dates |
| Last Update Posted: | January 28, 2022 |
| Last Verified: | April 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
|
ankyloglossia tongue-tie aromatherapy |
lavender pain neonate |
|
Ankyloglossia Stomatognathic Diseases |

